azotobactin has been researched along with nalidixic acid in 1 studies
*Nalidixic Acid: A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. [MeSH]
*Nalidixic Acid: A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. [MeSH]
| Studies (azotobactin) | Trials (azotobactin) | Recent Studies (post-2010) (azotobactin) | Studies (nalidixic acid) | Trials (nalidixic acid) | Recent Studies (post-2010) (nalidixic acid) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 3,246 | 87 | 340 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Page, WJ; Patrick, J | 1 |
1 other study(ies) available for azotobactin and nalidixic acid
| Article | Year |
|---|---|
The DNA gyrase inhibitors, nalidixic acid and oxolinic acid, prevent iron-mediated repression of catechol siderophore synthesis in Azotobacter vinelandii.
Topics: Azotobacter; Catechols; Iron; Iron Chelating Agents; Nalidixic Acid; Oxolinic Acid; Peptide Biosynthesis; Peptides; Siderophores; Time Factors; Topoisomerase II Inhibitors | 1988 |